Sagility shares are gaining attention. Nomura has initiated coverage with a Buy rating and a target price of Rs 55. This suggests significant upside potential. The company is expected to benefit from AI-driven transformations in healthcare services. Sagility's deep domain expertise positions it well. Domestic and foreign institutional investors have steadily increased their stakes.